Global Zebrafish Transgenesis and Gene Editing Services Market Growth (Status and Outlook) 2023-2029

Global Zebrafish Transgenesis and Gene Editing Services Market Growth (Status and Outlook) 2023-2029

The zebrafish is an important and widely used vertebrate model organism in scientific research, for example in drug development, in particular pre-clinical development. It is also notable for its regenerative abilities, and has been modified by researchers to produce many transgenic strains.

LPI (LP Information)' newest research report, the “Zebrafish Transgenesis and Gene Editing Services Industry Forecast” looks at past sales and reviews total world Zebrafish Transgenesis and Gene Editing Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Zebrafish Transgenesis and Gene Editing Services sales for 2023 through 2029. With Zebrafish Transgenesis and Gene Editing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Zebrafish Transgenesis and Gene Editing Services industry.

This Insight Report provides a comprehensive analysis of the global Zebrafish Transgenesis and Gene Editing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Zebrafish Transgenesis and Gene Editing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Zebrafish Transgenesis and Gene Editing Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Zebrafish Transgenesis and Gene Editing Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Zebrafish Transgenesis and Gene Editing Services.

The global Zebrafish Transgenesis and Gene Editing Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Zebrafish Transgenesis and Gene Editing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Zebrafish Transgenesis and Gene Editing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Zebrafish Transgenesis and Gene Editing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Zebrafish Transgenesis and Gene Editing Services players cover Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech and Bioreperia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Zebrafish Transgenesis and Gene Editing Services market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Disease ModelingGenetic Functional StudiesTarget Gene ValidationDisease Modeling
Genetic Functional Studies
Target Gene Validation

Segmentation by application
Pharmaceutical
Biotechnology

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
Ikan Biotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver.